Vunakizumab for adults with spondyloarthritis
Part of Bones, joints & muscles clinical trials.
This trial tests a new biologic drug called Vunakizumab for adults with spondyloarthritis (a type of arthritis affecting the spine). It aims to see if the drug can help control symptoms and inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with spondyloarthritis (not psoriatic arthritis).
- You are willing to use effective birth control if you are of childbearing age, for the study period and 20 weeks after.
- You do not have a serious active infection, moderate to severe heart failure, or an active cancer.
- You do not have other inflammatory diseases like inflammatory bowel disease that could interfere with the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called Vunakizumab for people with mild to moderate lupus that affects the skin or joints. It aims to see if adding this drug to your current treatment can help control symptoms better.
This study looks at how well vunakizumab works for people with certain inflammatory rheumatic conditions, like ankylosing spondylitis or psoriatic arthritis. It tracks symptoms, how the medicine is used, and any side effects over time.
This study tests a new drug called vunakizumab to see if it is safe and works well for people with moderate to severe plaque psoriasis. If you have not used biologic treatments before and meet other health requirements, you may be able to join.
This trial is testing the drug vunakizumab in people with inflammatory skin diseases. It aims to see how well the treatment works for different skin conditions.
This study tests a biologic called vunakizumab for people with moderate to severe plaque psoriasis who are already on biologic therapy and need to switch to another one. The goal is to see if it works well and is safe.
This study tests a new medication called vilamakitug for people with active axial spondyloarthritis. It aims to see if the drug can reduce pain and inflammation better than a placebo (a dummy treatment).
Hear when a new Spondyloarthritis (SpA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.